Literature DB >> 22781668

First FDA-approved beta-amyloid diagnostic hits the market.

Ken Garber.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22781668     DOI： 10.1038/nbt0712-575

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Use of florbetapir-PET for imaging beta-amyloid pathology.

Authors:  Christopher M Clark; Julie A Schneider; Barry J Bedell; Thomas G Beach; Warren B Bilker; Mark A Mintun; Michael J Pontecorvo; Franz Hefti; Alan P Carpenter; Matthew L Flitter; Michael J Krautkramer; Hank F Kung; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Marwan N Sabbagh; Carl H Sadowsky; Eric P Reiman; P Eric M Reiman; Simone P Zehntner; Daniel M Skovronsky
Journal:  JAMA       Date:  2011-01-19       Impact factor: 56.272
  1 in total
  2 in total

1.  Angelica tenuissima Nakai Ameliorates Cognitive Impairment and Promotes Neurogenesis in Mouse Model of Alzheimer's Disease.

Authors:  Minji Choi; Younghyurk Lee; Seung-Hun Cho
Journal:  Chin J Integr Med       Date:  2017-06-03       Impact factor: 1.978

2.  Close Correlation of Monoamine Oxidase Activity with Progress of Alzheimer's Disease in Mice, Observed by in Vivo Two-Photon Imaging.

Authors:  Dokyoung Kim; Sung Hoon Baik; Seokjo Kang; Seo Won Cho; Juryang Bae; Moon-Yong Cha; Michael J Sailor; Inhee Mook-Jung; Kyo Han Ahn
Journal:  ACS Cent Sci       Date:  2016-12-07       Impact factor: 14.553
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.